Investor Relations

Press Release

June 15, 2021

Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference

More
May 27, 2021

Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

More
May 7, 2021

Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin Subsidiary

More
May 6, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021

More
May 3, 2021

Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection

More
April 29, 2021

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 6th, 2021

More
April 6, 2021

Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference

More
March 29, 2021

Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection

More
March 15, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020

More
March 8, 2021

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021

More